nodes	percent_of_prediction	percent_of_DWPC	metapath
Mestranol—CYP2C9—Capecitabine—esophageal cancer	0.394	0.665	CbGbCtD
Mestranol—CYP2C9—Cisplatin—esophageal cancer	0.199	0.335	CbGbCtD
Mestranol—ESR1—AP-1 transcription factor network—CRTC1—esophageal cancer	0.0068	0.0185	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—SMG6—esophageal cancer	0.00636	0.0173	CbGpPWpGaD
Mestranol—Ethinyl Estradiol—NR1I2—esophageal cancer	0.00635	0.162	CrCbGaD
Mestranol—ESR1—FOXM1 transcription factor network—XRCC1—esophageal cancer	0.00632	0.0172	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—XBP1—esophageal cancer	0.00621	0.0169	CbGpPWpGaD
Mestranol—ESR1—Nuclear Receptor transcription pathway—NR1I2—esophageal cancer	0.00607	0.0165	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—PHB—esophageal cancer	0.0057	0.0155	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—SFN—esophageal cancer	0.00558	0.0152	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—NFE2L2—esophageal cancer	0.00546	0.0148	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX1—esophageal cancer	0.00493	0.0134	CbGpPWpGaD
Mestranol—CYP2C9—Xenobiotics—CYP2A6—esophageal cancer	0.00452	0.0123	CbGpPWpGaD
Mestranol—CYP2C9—Tamoxifen metabolism—CYP2A6—esophageal cancer	0.00435	0.0118	CbGpPWpGaD
Mestranol—Estradiol—NR1I2—esophageal cancer	0.00419	0.107	CrCbGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP26A1—esophageal cancer	0.00415	0.0113	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—esophageal cancer	0.00415	0.0113	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CHEK2—esophageal cancer	0.00408	0.0111	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—RUNX3—esophageal cancer	0.0039	0.0106	CbGpPWpGaD
Mestranol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCC2—esophageal cancer	0.00388	0.0105	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—CYP1B1—esophageal cancer	0.00379	0.0103	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—esophageal cancer	0.0037	0.01	CbGpPWpGaD
Mestranol—CYP2C9—Tamoxifen metabolism—CYP1B1—esophageal cancer	0.0035	0.00951	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—WWOX—esophageal cancer	0.00334	0.00908	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—SMAD4—esophageal cancer	0.00329	0.00893	CbGpPWpGaD
Mestranol—Estrone—CYP1B1—esophageal cancer	0.00318	0.0811	CrCbGaD
Mestranol—Levonorgestrel—CYP19A1—esophageal cancer	0.00317	0.0811	CrCbGaD
Mestranol—ESR1—Estrogen signaling pathway—BCL2—esophageal cancer	0.00313	0.00849	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—XRCC3—esophageal cancer	0.00312	0.00848	CbGpPWpGaD
Mestranol—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—esophageal cancer	0.0031	0.00843	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—ALOX15—esophageal cancer	0.00297	0.00806	CbGpPWpGaD
Mestranol—Danazol—CYP19A1—esophageal cancer	0.00289	0.0738	CrCbGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—NOS2—esophageal cancer	0.00289	0.00784	CbGpPWpGaD
Mestranol—Ethinyl Estradiol—ABCC2—esophageal cancer	0.00284	0.0726	CrCbGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—FKBP1A—esophageal cancer	0.00265	0.00719	CbGpPWpGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP26A1—esophageal cancer	0.00263	0.00715	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—ADH7—esophageal cancer	0.00262	0.00711	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP26A1—esophageal cancer	0.0026	0.00706	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ABCC2—esophageal cancer	0.00248	0.0634	CrCbGaD
Mestranol—Methyltestosterone—CYP19A1—esophageal cancer	0.00244	0.0624	CrCbGaD
Mestranol—Estradiol—CYP1B1—esophageal cancer	0.00241	0.0614	CrCbGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—SMAD4—esophageal cancer	0.00239	0.0065	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—ABL1—esophageal cancer	0.00235	0.00639	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—ADH1B—esophageal cancer	0.0023	0.00624	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CREBBP—esophageal cancer	0.00224	0.00608	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—RB1—esophageal cancer	0.00223	0.00606	CbGpPWpGaD
Mestranol—ESR1—FOXA1 transcription factor network—CREBBP—esophageal cancer	0.00216	0.00586	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP26A1—esophageal cancer	0.00213	0.0058	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—esophageal cancer	0.00212	0.00576	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—RB1—esophageal cancer	0.00208	0.00564	CbGpPWpGaD
Mestranol—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—esophageal cancer	0.00206	0.00559	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—PTGS1—esophageal cancer	0.00206	0.00559	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.00206	0.00558	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—NOS3—esophageal cancer	0.00204	0.00555	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—BAX—esophageal cancer	0.00199	0.00542	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD4—esophageal cancer	0.00198	0.00538	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CDKN2A—esophageal cancer	0.00196	0.00533	CbGpPWpGaD
Mestranol—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—esophageal cancer	0.00196	0.00533	CbGpPWpGaD
Mestranol—Estriol—ABCB1—esophageal cancer	0.00191	0.0489	CrCbGaD
Mestranol—ESR1—ATF-2 transcription factor network—NOS2—esophageal cancer	0.0019	0.00516	CbGpPWpGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—esophageal cancer	0.00188	0.0051	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—esophageal cancer	0.00185	0.00503	CbGpPWpGaD
Mestranol—ESR1—Estrogen signaling pathway—PIK3CA—esophageal cancer	0.00183	0.00496	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—HIF1A—esophageal cancer	0.00182	0.00495	CbGpPWpGaD
Mestranol—Estramustine—ABCB1—esophageal cancer	0.00178	0.0455	CrCbGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—CYP1B1—esophageal cancer	0.00175	0.00475	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—esophageal cancer	0.00171	0.00463	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—RB1—esophageal cancer	0.0017	0.00462	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—ANXA1—esophageal cancer	0.00169	0.00458	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—CCND1—esophageal cancer	0.00166	0.0045	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.00162	0.00439	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—EP300—esophageal cancer	0.00153	0.00414	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.00152	0.00413	CbGpPWpGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.00151	0.00411	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.00149	0.00405	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—CDKN1A—esophageal cancer	0.00149	0.00405	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—BCL2—esophageal cancer	0.00147	0.004	CbGpPWpGaD
Mestranol—ESR1—FOXA1 transcription factor network—EP300—esophageal cancer	0.00147	0.00399	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CHEK2—esophageal cancer	0.00147	0.00398	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	0.00144	0.00392	CbGpPWpGaD
Mestranol—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	0.00142	0.00386	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—EP300—esophageal cancer	0.00142	0.00385	CbGpPWpGaD
Mestranol—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	0.0014	0.00381	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	0.0014	0.0038	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—ADH7—esophageal cancer	0.00139	0.00378	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CYP19A1—esophageal cancer	0.00138	0.00373	CbGpPWpGaD
Mestranol—ESR1—FOXM1 transcription factor network—MYC—esophageal cancer	0.00133	0.00361	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—CREBBP—esophageal cancer	0.00132	0.0036	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—MYC—esophageal cancer	0.0013	0.00354	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CDKN2A—esophageal cancer	0.0013	0.00354	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	0.00128	0.00347	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TGFBR2—esophageal cancer	0.00127	0.00345	CbGpPWpGaD
Mestranol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—esophageal cancer	0.00126	0.00343	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—CCND1—esophageal cancer	0.00126	0.00343	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—NOS3—esophageal cancer	0.00126	0.00343	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—ABL1—esophageal cancer	0.00124	0.00338	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—MYC—esophageal cancer	0.00124	0.00336	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	0.00123	0.00333	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—ADH1B—esophageal cancer	0.00122	0.00331	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	0.00122	0.0033	CbGpPWpGaD
Mestranol—ESR1—Aryl Hydrocarbon Receptor—EGFR—esophageal cancer	0.00121	0.00328	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—SMAD4—esophageal cancer	0.0012	0.00327	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—CCND1—esophageal cancer	0.00118	0.00321	CbGpPWpGaD
Mestranol—ESR1—Leptin signaling pathway—ERBB2—esophageal cancer	0.00118	0.0032	CbGpPWpGaD
Mestranol—ESR1—ATF-2 transcription factor network—EP300—esophageal cancer	0.00116	0.00316	CbGpPWpGaD
Mestranol—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	0.00115	0.00313	CbGpPWpGaD
Mestranol—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—esophageal cancer	0.00115	0.00312	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BAX—esophageal cancer	0.00114	0.00309	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP26A1—esophageal cancer	0.00113	0.00308	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—CCND1—esophageal cancer	0.00113	0.00306	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP26A1—esophageal cancer	0.00112	0.00304	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—CCND1—esophageal cancer	0.0011	0.00299	CbGpPWpGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—EP300—esophageal cancer	0.00109	0.00296	CbGpPWpGaD
Mestranol—ESR1—LKB1 signaling events—TP53—esophageal cancer	0.00107	0.00291	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTO1—esophageal cancer	0.00105	0.00286	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.00105	0.00285	CbGpPWpGaD
Mestranol—Ethinyl Estradiol—ABCB1—esophageal cancer	0.00105	0.0267	CrCbGaD
Mestranol—ESR1—Leptin signaling pathway—CCND1—esophageal cancer	0.00104	0.00283	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—GSTO1—esophageal cancer	0.00104	0.00282	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	0.00103	0.0028	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—EP300—esophageal cancer	0.00101	0.00275	CbGpPWpGaD
Mestranol—Norethindrone—ABCB1—esophageal cancer	0.00101	0.0257	CrCbGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	0.000998	0.00271	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—esophageal cancer	0.000998	0.00271	CbGpPWpGaD
Mestranol—Dextromethorphan—ABCB1—esophageal cancer	0.000949	0.0242	CrCbGaD
Mestranol—ESR1—Validated nuclear estrogen receptor alpha network—MYC—esophageal cancer	0.000949	0.00258	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	0.000948	0.00257	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	0.000944	0.00256	CbGpPWpGaD
Mestranol—Conjugated Estrogens—ABCB1—esophageal cancer	0.000914	0.0233	CrCbGaD
Mestranol—Estrone—ABCB1—esophageal cancer	0.000911	0.0233	CrCbGaD
Mestranol—ESR1—Regulation of Telomerase—MYC—esophageal cancer	0.000904	0.00246	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	0.000902	0.00245	CbGpPWpGaD
Mestranol—ESR1—Regulation of Telomerase—EGFR—esophageal cancer	0.000885	0.0024	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—MYC—esophageal cancer	0.000884	0.0024	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—ALDH2—esophageal cancer	0.000859	0.00233	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—GSTT1—esophageal cancer	0.000817	0.00222	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CASP8—esophageal cancer	0.000809	0.0022	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP2A6—esophageal cancer	0.000808	0.00219	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—RB1—esophageal cancer	0.000802	0.00218	CbGpPWpGaD
Mestranol—CYP2C9—Arachidonic acid metabolism—PTGS2—esophageal cancer	0.000789	0.00214	CbGpPWpGaD
Mestranol—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	0.000786	0.00213	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—PTGS1—esophageal cancer	0.000766	0.00208	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GDI2—esophageal cancer	0.000735	0.00199	CbGpPWpGaD
Mestranol—ESR1—AP-1 transcription factor network—TP53—esophageal cancer	0.000726	0.00197	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—BCL2—esophageal cancer	0.000694	0.00188	CbGpPWpGaD
Mestranol—Estradiol—ABCB1—esophageal cancer	0.000691	0.0176	CrCbGaD
Mestranol—ESR1—Signaling by ERBB4—ERBB2—esophageal cancer	0.000671	0.00182	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	0.00067	0.00182	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	0.000667	0.00181	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SMG6—esophageal cancer	0.000666	0.00181	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH3—esophageal cancer	0.000658	0.00179	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP1B1—esophageal cancer	0.000651	0.00177	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP1B1—esophageal cancer	0.000642	0.00174	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—SLC10A2—esophageal cancer	0.000628	0.00171	CbGpPWpGaD
Mestranol—CYP2C9—Biological oxidations—CYP19A1—esophageal cancer	0.000612	0.00166	CbGpPWpGaD
Mestranol—CYP2C9—Metapathway biotransformation—CYP19A1—esophageal cancer	0.000604	0.00164	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—CCND1—esophageal cancer	0.000596	0.00162	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH2—esophageal cancer	0.00059	0.0016	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	0.000575	0.00156	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—CDKN1A—esophageal cancer	0.000573	0.00156	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	0.000559	0.00152	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—EP300—esophageal cancer	0.000548	0.00149	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	0.000546	0.00148	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KMT2D—esophageal cancer	0.000531	0.00144	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NR1I2—esophageal cancer	0.000505	0.00137	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—SMAD4—esophageal cancer	0.000496	0.00135	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	0.000493	0.00134	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—MYC—esophageal cancer	0.000478	0.0013	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	0.000477	0.0013	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ADCYAP1—esophageal cancer	0.000473	0.00129	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—EGFR—esophageal cancer	0.000467	0.00127	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—EGFR—esophageal cancer	0.000465	0.00126	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	0.000454	0.00123	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—HIST1H2BM—esophageal cancer	0.000433	0.00118	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—WWOX—esophageal cancer	0.000433	0.00118	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.000424	0.00115	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FKBP1A—esophageal cancer	0.000412	0.00112	CbGpPWpGaD
Mestranol—ESR1—Signaling by ERBB4—PIK3CA—esophageal cancer	0.000403	0.0011	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—WIF1—esophageal cancer	0.000402	0.00109	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	0.000396	0.00107	CbGpPWpGaD
Mestranol—ESR1—Integrated Breast Cancer Pathway—TP53—esophageal cancer	0.000392	0.00107	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	0.000387	0.00105	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CSNK1A1—esophageal cancer	0.000371	0.00101	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	0.00037	0.00101	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000365	0.000992	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PFN1—esophageal cancer	0.000347	0.000943	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	0.000336	0.000912	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PSME1—esophageal cancer	0.000336	0.000912	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—PSME2—esophageal cancer	0.000336	0.000912	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—CREBBP—esophageal cancer	0.000331	0.0009	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—BLVRB—esophageal cancer	0.000329	0.000894	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC52A3—esophageal cancer	0.000329	0.000894	CbGpPWpGaD
Mestranol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	0.000325	0.000883	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH3—esophageal cancer	0.000317	0.00086	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ELMO1—esophageal cancer	0.000312	0.000847	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—AKAP13—esophageal cancer	0.000305	0.000828	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	0.000294	0.000799	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH2—esophageal cancer	0.000284	0.000772	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIST1H2BM—esophageal cancer	0.000281	0.000764	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—SLC10A2—esophageal cancer	0.00028	0.00076	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CA1—esophageal cancer	0.00028	0.00076	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PDE4D—esophageal cancer	0.000279	0.000758	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GNG7—esophageal cancer	0.000265	0.000721	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CA2—esophageal cancer	0.000256	0.000695	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	0.00025	0.000679	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—XIAP—esophageal cancer	0.000249	0.000675	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—SMAD4—esophageal cancer	0.000239	0.000648	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ADH7—esophageal cancer	0.000238	0.000646	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PLCE1—esophageal cancer	0.000238	0.000646	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	0.000235	0.000639	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CTNNA1—esophageal cancer	0.000235	0.000638	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CXCL2—esophageal cancer	0.000234	0.000635	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PSME1—esophageal cancer	0.000218	0.000593	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PSME2—esophageal cancer	0.000218	0.000593	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ANXA1—esophageal cancer	0.000217	0.00059	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SST—esophageal cancer	0.000211	0.000574	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ADH1B—esophageal cancer	0.000209	0.000566	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH3—esophageal cancer	0.000206	0.000559	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—GHRL—esophageal cancer	0.000206	0.000559	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—FBXW7—esophageal cancer	0.000203	0.00055	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TYMP—esophageal cancer	0.000199	0.000541	CbGpPWpGaD
Mestranol—ESR1—Generic Transcription Pathway—MYC—esophageal cancer	0.000197	0.000534	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP26A1—esophageal cancer	0.000194	0.000527	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALOX15—esophageal cancer	0.000189	0.000513	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH2—esophageal cancer	0.000185	0.000502	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—TPI1—esophageal cancer	0.00018	0.00049	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTO1—esophageal cancer	0.00018	0.00049	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—NOTCH1—esophageal cancer	0.000176	0.000478	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALDOB—esophageal cancer	0.000173	0.000469	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GAPDH—esophageal cancer	0.000166	0.000452	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CRABP1—esophageal cancer	0.000165	0.000448	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TGFBR2—esophageal cancer	0.000164	0.000445	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—CREBBP—esophageal cancer	0.00016	0.000433	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GNG7—esophageal cancer	0.000157	0.000426	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—SMAD4—esophageal cancer	0.000155	0.000421	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ALDH2—esophageal cancer	0.000147	0.000399	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—GSTT1—esophageal cancer	0.00014	0.00038	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP2A6—esophageal cancer	0.000138	0.000375	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	0.000138	0.000374	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS1—esophageal cancer	0.000131	0.000356	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ENO1—esophageal cancer	0.000131	0.000356	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PSME1—esophageal cancer	0.000129	0.000351	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PSME2—esophageal cancer	0.000129	0.000351	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—HIF1A—esophageal cancer	0.000127	0.000345	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—KDR—esophageal cancer	0.000121	0.00033	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOTCH1—esophageal cancer	0.000114	0.000311	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	0.000113	0.000306	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP1B1—esophageal cancer	0.000111	0.000302	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CYP19A1—esophageal cancer	0.000105	0.000284	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CREBBP—esophageal cancer	0.000104	0.000282	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—HMOX1—esophageal cancer	9.56e-05	0.00026	CbGpPWpGaD
Mestranol—ESR1—Gene Expression—MYC—esophageal cancer	9.47e-05	0.000257	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	9.38e-05	0.000255	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—NOS3—esophageal cancer	9.29e-05	0.000252	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—ABCB1—esophageal cancer	9.17e-05	0.000249	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—ERBB2—esophageal cancer	8.69e-05	0.000236	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CCND1—esophageal cancer	7.67e-05	0.000208	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—CDKN1A—esophageal cancer	7.42e-05	0.000202	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EP300—esophageal cancer	7.06e-05	0.000192	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	6.94e-05	0.000188	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—MYC—esophageal cancer	6.16e-05	0.000167	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—CREBBP—esophageal cancer	6.13e-05	0.000166	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—EGFR—esophageal cancer	6.02e-05	0.000163	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—NOS3—esophageal cancer	5.49e-05	0.000149	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—PIK3CA—esophageal cancer	5.23e-05	0.000142	CbGpPWpGaD
Mestranol—ESR1—Signaling Pathways—TP53—esophageal cancer	5.05e-05	0.000137	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PTGS2—esophageal cancer	5.02e-05	0.000136	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—EP300—esophageal cancer	4.18e-05	0.000113	CbGpPWpGaD
Mestranol—CYP2C9—Metabolism—PIK3CA—esophageal cancer	3.09e-05	8.39e-05	CbGpPWpGaD
